Literature DB >> 24819543

Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al.

Zoya Kuzmina1, Galen O Joe, Kristin Baird, Edward W Cowen, Haley B Naik, Seth M Steinberg, Lauren Curtis, Leora E Comis, Steven Z Pavletic.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24819543      PMCID： PMC4212407          DOI： 10.1002/art.38697

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  5 in total

1.  How I conduct a comprehensive chronic graft-versus-host disease assessment.

Authors:  Paul A Carpenter
Journal:  Blood       Date:  2011-06-30       Impact factor: 22.113

2.  Assessment of joint and fascia manifestations in chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Joseph Pidala; Xiaoyu Chai; Brenda F Kurland; Daniel Weisdorf; Mary E D Flowers; Jeanne Palmer; Sally Arai; David Jacobsohn; Corey Cutler; Madan Jagasia; Jenna D Goldberg; Paul J Martin; Steven Z Pavletic; Georgia B Vogelsang; Stephanie J Lee; Paul A Carpenter
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

3.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

4.  Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.

Authors:  Stephanie k Lee; E Francis Cook; Robert Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

5.  Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.

Authors:  L Grkovic; K Baird; S M Steinberg; K M Williams; D Pulanic; E W Cowen; S A Mitchell; F T Hakim; K J Martires; D N Avila; T N Taylor; R B Salit; S D Rowley; D Zhang; D H Fowler; M R Bishop; R E Gress; S Z Pavletic
Journal:  Leukemia       Date:  2011-10-18       Impact factor: 11.528
  5 in total
  7 in total

Review 1.  Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.

Authors:  Cristina Hidalgo Calleja; Daniel Martín Hidalgo; Concepción Román Curto; Lourdes Vázquez López; Estefanía Pérez López; Mónica Cabrero Calvo; Ana África Martín López; María Dolores Caballero Barrigón; Lucía Lopez-Corral
Journal:  Adv Rheumatol       Date:  2022-08-23

Review 2.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

3.  EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Authors:  Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2018-06-05       Impact factor: 5.483

4.  Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.

Authors:  Ana Zelic Kerep; Filip Pirsl; Seth Steinberg; Sandra Mitchell; Lauren Curtis; Noa Holtzman; Sencer Goklemez; Ervina Bilic; Edward Cowen; Dominique Pichard; Galen Joe; Leora Comis; Annie Im; Ann Berger; Laura Parsons-Wandell; Drazen Pulanic; Kristin Baird; Ronald Gress; Steven Pavletic
Journal:  Hemasphere       Date:  2022-05-31

5.  Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

Authors:  Yoshihiro Inamoto; Stephanie J Lee; Lynn E Onstad; Mary E D Flowers; Betty K Hamilton; Madan H Jagasia; Paul J Martin; Steven Z Pavletic; Joseph A Pidala; Iskra Pusic; Georgia B Vogelsang; Daniel Wolff; Paul A Carpenter
Journal:  Blood Adv       Date:  2020-01-14

6.  A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.

Authors:  Lauren M Curtis; Alen Ostojic; David J Venzon; Noa G Holtzman; Filip Pirsl; Zoya J Kuzmina; Kristin Baird; Jeremy J Rose; Edward W Cowen; Jacqueline W Mays; Sandra A Mitchell; Laura Parsons-Wandell; Galen O Joe; Leora E Comis; Ann Berger; Iskra Pusic; Cody J Peer; William D Figg; Liang Cao; Robert Peter Gale; Frances T Hakim; Steven Z Pavletic
Journal:  Blood       Date:  2021-02-18       Impact factor: 22.113

7.  Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.

Authors:  Tamara Vukić; Sean Robinson Smith; Dina Ljubas Kelečić; Lana Desnica; Ema Prenc; Dražen Pulanić; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Croat Med J       Date:  2016-06-30       Impact factor: 1.351
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.